Prevention of Emesis from Multiple-Day and High-Dose Chemotherapy Regimens

Author： Navari Rudolph M.  

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.5, Iss.1, 2007-01, pp. : 51-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-dose chemotherapy + stem cells for multiple myeloma

By  

Inpharma, Vol. 1, Iss. 1387, 2003-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Single‐ and Multiple‐Day Dosing Studies to Investigate High‐Dose Pharmacokinetics of Epelsiban and Its Metabolite, GSK2395448, in Healthy Female Volunteers

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 1, 2018-01 ,pp. : 33-43

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacodynamics of High-Dose Chemotherapy

By  

Current Drug Metabolism, Vol. 2, Iss. 1, 2001-03 ,pp. : 53-66

Bentham Science Publishers

Access to resources Recommend Favorite

High-dose chemotherapy: no survival benefit

By  

Inpharma, Vol. 1, Iss. 1229, 2000-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

High-Dose Chemotherapy in Breast Cancer

By Lake Diana E.   Hudis Clifford A.  

Drugs, Vol. 64, Iss. 17, 2004-01 ,pp. : 1851-1860

Adis International

Access to resources Recommend Favorite